Evidence map›Paper›PMID 30758990›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2019

Prostaglandin E

Subhendu Mukherjee, Wei Sheng, Alexander Michkov, Krishna Sriarm, Rui Sun, Anna Dvorkin-Gheva, Paul A Insel, Luke J Janssen

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Prostaglandin EFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  11. Dopamine Receptor D1 Is Exempt from Transforming Growth FactorThe Journal of pharmacology and experimental therapeutics · 2023
    Article
  12. Prostaglandin E2 (PGE2) and Roflumilast Involvement in IPF Progression.International journal of molecular sciences · 2023
    Review
  13. Lipid metabolism in idiopathic pulmonary fibrosis: From pathogenesis to therapy.Journal of molecular medicine (Berlin, Germany) · 2023
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Basal-Like Cell-Conditioned Medium Exerts Anti-Fibrotic EffectsFrontiers in bioengineering and biotechnology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Subhendu MukherjeeFirestone Institute for Respiratory Health, St. Joseph's Hospital, Department of Medicine, McMaster University , Hamilton, Ontario , Canada.
Wei ShengFirestone Institute for Respiratory Health, St. Joseph's Hospital, Department of Medicine, McMaster University , Hamilton, Ontario , Canada.
Alexander MichkovDepartment of Pharmacology, University of California, San Diego, La Jolla, California.
Krishna SriarmDepartment of Pharmacology, University of California, San Diego, La Jolla, California.
Rui SunFirestone Institute for Respiratory Health, St. Joseph's Hospital, Department of Medicine, McMaster University , Hamilton, Ontario , Canada.
Anna Dvorkin-GhevaMcMaster Immunology Research Centre, Department of Pathology, McMaster University, Hamilton, Ontario, Canada.
Paul A InselDepartment of Pharmacology, University of California, San Diego, La Jolla, California.
Luke J JanssenFirestone Institute for Respiratory Health, St. Joseph's Hospital, Department of Medicine, McMaster University , Hamilton, Ontario , Canada.
University of California, San Diego · USSt. Joseph's Hospital · CAMcMaster University · CAMcMaster University Medical Centre · CASt. Joseph’s Healthcare Hamilton · CA

Funding

Training in Respiratory Biology: Innovate, Integrate, and TranslateT32HL098062 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI POWELL, FRANK L. · 2010 to 2014
$2.1M
NHLBI NIH HHS T32 HL098062
6 · The paper itself

Abstract

We have shown that calcium (Ca

Indexed as

AgedAged, 80 and overCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium SignalingCells, CulturedDinoprostoneExtracellular Signal-Regulated MAP KinasesFemaleFibroblastsGene Expression RegulationHumansLungMaleMiddle AgedProto-Oncogene Proteins c-aktPulmonary FibrosisCalcium-Calmodulin-Dependent Protein Kinase Type 2DinoprostoneExtracellular Signal-Regulated MAP KinasesProto-Oncogene Proteins c-aktReceptors, Prostaglandin E, EP2 SubtypeSmad2 ProteinSMAD2 protein, humanTransforming Growth Factor betaCa signalingextracellular matrix genefibrosisPGEprostaglandin Eprostanoid receptor

Identifiers

PMID30758990
PMCPMC6589580
OpenAlexW2912352885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.